Legacy AI grade · Sources dated 2026-06-09. Not expert reviewed. Coverage is limited to the listed sources. About the new summary workflow
Vitamin A for Dry Eye Disease
Across 4 PubMed studies, the evidence for Vitamin A in Dry Eye Disease grades Tier C — weak evidence. Effective, but with safety or population caveats.
Why this grade7-layer evidence engine
Vitamin A for dry eye has limited RCT support. True vitamin-A monotherapy RCTs are approximately two: PMID 18848318 (open-label) and PMID 28694687. PMID 31040640 is short-term observational, and PMID 27274185 tests a multi-antioxidant combination.
L11 independently grades B while published tier is C after cap. The evidence base is small and methodologically mixed, with combination products inflating the apparent RCT count.
Tier C reflects weak, surrogate-heavy evidence. Deficiency correction may help some patients, but routine vitamin-A supplementation for dry eye is not well supported.
Scoring transparency
All scores computed by a 7-layer evidence engine — fully auditable▸View the full decision path (audit trail)
- compute_raw_score — 加權公式: L2×0.30 + L3×0.25 + L5×0.25 + L11×0.10 + L1×0.10 = 0.518
- tier_from_score — 依分數區間映射至 tier letter
- apply_hec_rules — 無高階證據可裁決
- tier_strict_requirement_check — Tier 條件達標,未降階
- detect_disputes — 偵測到 0 個 hard + 1 個 soft dispute
- decide_status — 依 tier + dispute 結果決定 status